Selected research
Market Structure
Global GFAP Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global GFAP Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for GFAP Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for GFAP Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GFAP Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for GFAP Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of GFAP Antibody include Merck, Synaptic Systems, Sino Biological, Santa Cruz Biotechnology, Proteintech, ProSci, Miltenyi Biotec, Hytest and GeneTex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global GFAP Antibody market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of GFAP Antibody and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GFAP Antibody revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the GFAP Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.
GFAP Antibody Segment by Company
Merck
Synaptic Systems
Sino Biological
Santa Cruz Biotechnology
Proteintech
ProSci
Miltenyi Biotec
Hytest
GeneTex
FineTest
Enzo Life Sciences
EnCor Biotechnology
Aviva Systems Biology
Atlas Antibodies
GFAP Antibody Segment by Type
Polyclonal
Monoclonal
GFAP Antibody Segment by Application
Immunohistochemistry Paraffin
Immunohistochemistry Frozen
Immunofluorescence
Western Blot
Others
GFAP Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GFAP Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GFAP Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GFAP Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of GFAP Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GFAP Antibody industry.
Chapter 3: Detailed analysis of GFAP Antibody companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GFAP Antibodyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Immunohistochemistry Paraffin
- Immunohistochemistry Frozen
- Immunofluorescence
- Western Blot
- Others
Companies covered
- Merck
- Synaptic Systems
- Sino Biological
- Santa Cruz Biotechnology
- Proteintech
- ProSci
- Miltenyi Biotec
- Hytest
- GeneTex
- FineTest
- Enzo Life Sciences
- EnCor Biotechnology
- Aviva Systems Biology
- Atlas Antibodies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global GFAP Antibody Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Polyclonal
- 1.2.3 Monoclonal
- 1.3 Market Analysis by Application
- 1.3.1 Global GFAP Antibody Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Immunohistochemistry Paraffin
- 1.3.3 Immunohistochemistry Frozen
- 1.3.4 Immunofluorescence
- 1.3.5 Western Blot
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global GFAP Antibody Growth Trends by Region
- 1.5.1 Global GFAP Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 GFAP Antibody Market Size by Region (2021-2026)
- 1.5.3 GFAP Antibody Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global GFAP Antibody Market Dynamics
- 2.1 GFAP Antibody Industry Trends
- 2.2 GFAP Antibody Industry Drivers
- 2.3 GFAP Antibody Industry Opportunities and Challenges
- 2.4 GFAP Antibody Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global GFAP Antibody Revenue by Company (2021-2026)
- 3.2 Global GFAP Antibody Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global GFAP Antibody Key Company Head office and Area Served
- 3.4 Global GFAP Antibody Company, Product Type & Application
- 3.5 Global GFAP Antibody Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global GFAP Antibody Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 GFAP Antibody Players Market Share by Revenue in 2025
- 3.6.3 2025 GFAP Antibody Tier 1, Tier 2, and Tier 3
4 GFAP Antibody Market by Type
- 4.1 Global GFAP Antibody Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global GFAP Antibody Market Size by Type (2021-2032)
- 4.3 Global GFAP Antibody Market Size Share by Type (2021-2032)
5 GFAP Antibody Market by Application
- 5.1 Global GFAP Antibody Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global GFAP Antibody Market Size by Application (2021-2032)
- 5.3 Global GFAP Antibody Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Merck GFAP Antibody Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Synaptic Systems
- 6.2.1 Synaptic Systems Company Information
- 6.2.2 Synaptic Systems Business Overview
- 6.2.3 Synaptic Systems GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Synaptic Systems GFAP Antibody Product Portfolio
- 6.2.5 Synaptic Systems Recent Developments
- 6.3 Sino Biological
- 6.3.1 Sino Biological Company Information
- 6.3.2 Sino Biological Business Overview
- 6.3.3 Sino Biological GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Sino Biological GFAP Antibody Product Portfolio
- 6.3.5 Sino Biological Recent Developments
- 6.4 Santa Cruz Biotechnology
- 6.4.1 Santa Cruz Biotechnology Company Information
- 6.4.2 Santa Cruz Biotechnology Business Overview
- 6.4.3 Santa Cruz Biotechnology GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Santa Cruz Biotechnology GFAP Antibody Product Portfolio
- 6.4.5 Santa Cruz Biotechnology Recent Developments
- 6.5 Proteintech
- 6.5.1 Proteintech Company Information
- 6.5.2 Proteintech Business Overview
- 6.5.3 Proteintech GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Proteintech GFAP Antibody Product Portfolio
- 6.5.5 Proteintech Recent Developments
- 6.6 ProSci
- 6.6.1 ProSci Company Information
- 6.6.2 ProSci Business Overview
- 6.6.3 ProSci GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 ProSci GFAP Antibody Product Portfolio
- 6.6.5 ProSci Recent Developments
- 6.7 Miltenyi Biotec
- 6.7.1 Miltenyi Biotec Company Information
- 6.7.2 Miltenyi Biotec Business Overview
- 6.7.3 Miltenyi Biotec GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Miltenyi Biotec GFAP Antibody Product Portfolio
- 6.7.5 Miltenyi Biotec Recent Developments
- 6.8 Hytest
- 6.8.1 Hytest Company Information
- 6.8.2 Hytest Business Overview
- 6.8.3 Hytest GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Hytest GFAP Antibody Product Portfolio
- 6.8.5 Hytest Recent Developments
- 6.9 GeneTex
- 6.9.1 GeneTex Company Information
- 6.9.2 GeneTex Business Overview
- 6.9.3 GeneTex GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 GeneTex GFAP Antibody Product Portfolio
- 6.9.5 GeneTex Recent Developments
- 6.10 FineTest
- 6.10.1 FineTest Company Information
- 6.10.2 FineTest Business Overview
- 6.10.3 FineTest GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 FineTest GFAP Antibody Product Portfolio
- 6.10.5 FineTest Recent Developments
- 6.11 Enzo Life Sciences
- 6.11.1 Enzo Life Sciences Company Information
- 6.11.2 Enzo Life Sciences Business Overview
- 6.11.3 Enzo Life Sciences GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Enzo Life Sciences GFAP Antibody Product Portfolio
- 6.11.5 Enzo Life Sciences Recent Developments
- 6.12 EnCor Biotechnology
- 6.12.1 EnCor Biotechnology Company Information
- 6.12.2 EnCor Biotechnology Business Overview
- 6.12.3 EnCor Biotechnology GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 EnCor Biotechnology GFAP Antibody Product Portfolio
- 6.12.5 EnCor Biotechnology Recent Developments
- 6.13 Aviva Systems Biology
- 6.13.1 Aviva Systems Biology Company Information
- 6.13.2 Aviva Systems Biology Business Overview
- 6.13.3 Aviva Systems Biology GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Aviva Systems Biology GFAP Antibody Product Portfolio
- 6.13.5 Aviva Systems Biology Recent Developments
- 6.14 Atlas Antibodies
- 6.14.1 Atlas Antibodies Company Information
- 6.14.2 Atlas Antibodies Business Overview
- 6.14.3 Atlas Antibodies GFAP Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Atlas Antibodies GFAP Antibody Product Portfolio
- 6.14.5 Atlas Antibodies Recent Developments
7 North America
- 7.1 North America GFAP Antibody Market Size (2021-2032)
- 7.2 North America GFAP Antibody Market Size by Type
- 7.2.1 North America GFAP Antibody Market Size by Type (2021-2026)
- 7.2.2 North America GFAP Antibody Market Size by Type (2027-2032)
- 7.2.3 North America GFAP Antibody Market Share by Type (2021-2032)
- 7.3 North America GFAP Antibody Market Size by Application
- 7.3.1 North America GFAP Antibody Market Size by Application (2021-2026)
- 7.3.2 North America GFAP Antibody Market Size by Application (2027-2032)
- 7.3.3 North America GFAP Antibody Market Share by Application (2021-2032)
- 7.4 North America GFAP Antibody Market Size by Country
- 7.4.1 North America GFAP Antibody Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America GFAP Antibody Market Size by Country (2021-2026)
- 7.4.3 North America GFAP Antibody Market Size by Country (2027-2032)
- 7.4.4 North America GFAP Antibody Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe GFAP Antibody Market Size (2021-2032)
- 8.2 Europe GFAP Antibody Market Size by Type
- 8.2.1 Europe GFAP Antibody Market Size by Type (2021-2026)
- 8.2.2 Europe GFAP Antibody Market Size by Type (2027-2032)
- 8.2.3 Europe GFAP Antibody Market Share by Type (2021-2032)
- 8.3 Europe GFAP Antibody Market Size by Application
- 8.3.1 Europe GFAP Antibody Market Size by Application (2021-2026)
- 8.3.2 Europe GFAP Antibody Market Size by Application (2027-2032)
- 8.3.3 Europe GFAP Antibody Market Share by Application (2021-2032)
- 8.4 Europe GFAP Antibody Market Size by Country
- 8.4.1 Europe GFAP Antibody Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe GFAP Antibody Market Size by Country (2021-2026)
- 8.4.3 Europe GFAP Antibody Market Size by Country (2027-2032)
- 8.4.4 Europe GFAP Antibody Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China GFAP Antibody Market Size (2021-2032)
- 9.2 China GFAP Antibody Market Size by Type
- 9.2.1 China GFAP Antibody Market Size by Type (2021-2026)
- 9.2.2 China GFAP Antibody Market Size by Type (2027-2032)
- 9.2.3 China GFAP Antibody Market Share by Type (2021-2032)
- 9.3 China GFAP Antibody Market Size by Application
- 9.3.1 China GFAP Antibody Market Size by Application (2021-2026)
- 9.3.2 China GFAP Antibody Market Size by Application (2027-2032)
- 9.3.3 China GFAP Antibody Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia GFAP Antibody Market Size (2021-2032)
- 10.2 Asia GFAP Antibody Market Size by Type
- 10.2.1 Asia GFAP Antibody Market Size by Type (2021-2026)
- 10.2.2 Asia GFAP Antibody Market Size by Type (2027-2032)
- 10.2.3 Asia GFAP Antibody Market Share by Type (2021-2032)
- 10.3 Asia GFAP Antibody Market Size by Application
- 10.3.1 Asia GFAP Antibody Market Size by Application (2021-2026)
- 10.3.2 Asia GFAP Antibody Market Size by Application (2027-2032)
- 10.3.3 Asia GFAP Antibody Market Share by Application (2021-2032)
- 10.4 Asia GFAP Antibody Market Size by Country
- 10.4.1 Asia GFAP Antibody Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia GFAP Antibody Market Size by Country (2021-2026)
- 10.4.3 Asia GFAP Antibody Market Size by Country (2027-2032)
- 10.4.4 Asia GFAP Antibody Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa GFAP Antibody Market Size (2021-2032)
- 11.2 South America, Middle East & Africa GFAP Antibody Market Size by Type
- 11.2.1 South America, Middle East & Africa GFAP Antibody Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa GFAP Antibody Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa GFAP Antibody Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa GFAP Antibody Market Size by Application
- 11.3.1 South America, Middle East & Africa GFAP Antibody Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa GFAP Antibody Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa GFAP Antibody Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa GFAP Antibody Market Size by Country
- 11.4.1 South America, Middle East & Africa GFAP Antibody Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa GFAP Antibody Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa GFAP Antibody Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa GFAP Antibody Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst